165438+1On October 24th, Beidao Finance learned that Neusoft Medical System Co., Ltd. (hereinafter referred to as "Neusoft Medical") had obtained the approval of China Securities Regulatory Commission for issuing overseas listed foreign shares. This means that Neusoft Medical will issue shares overseas and will be listed on the Hong Kong Stock Exchange. At present, Neusoft Medical has not passed the hearing of the Hong Kong Stock Exchange. According to the data, Neusoft Medical submitted its application for listing on the Hong Kong Stock Exchange on May 3, 20265438, and it has been nearly half a year. According to progress, Neusoft Medical will hold a hearing in the near future.

1. According to the previous prospectus, Neusoft Medical was established in 1998. It is a global provider of medical imaging solutions and services, developing, manufacturing and distributing all kinds of advanced technical imaging, treatment and diagnosis products for medical service providers in China and around the world. It is understood that Neusoft Medical is behind Neusoft Group (6007 18. Shh). In the shareholding structure before listing in Hong Kong, Neusoft Group held 29.94%, Wei Zhi Global held 26.52%, Neusoft Holdings held 15.5 1%, Dalian Kangruidao held 8.92%, and Tianjin Wang Mai, an employee-owned platform, held 5.00%.

2. Among them, Liu Jiren, the chairman of Neusoft Medical, actually controls 40.47% shares of Neusoft Holdings through Dalian Kangrui Road. At the same time, Neusoft Holdings is also the largest shareholder of Neusoft Group, holding 65,438+02.97% shares of the latter. This means that Liu Jiren is the ultimate actual controller of the company.

3. According to yost Sullivan's data, Neusoft Medical is the largest CT system manufacturer in China based on the total number of system installations and total revenue in 20 19 years. According to the sales volume of 20 19, Neusoft Medical is also the largest exporter of CT systems in China.

4. According to the prospectus submitted by Neusoft Medical on the Science and Technology Innovation Board, by the end of 20 19, Neusoft Medical had 2,573 sets of CT equipment in the China market, accounting for 0.4% of the China market share/kloc-0, ranking first among domestic brands, only next to GE, Siemens and Philips.

5.20 18, 20 19, and in 2020, Neusoft's medical operating income was191200 million yuan,1908 million yuan, and 2.459 billion yuan, respectively, all of which maintained the growth trend; The net profit was 654.38+69 million yuan, 82.04 million yuan and 92.758 million yuan respectively, of which 2065.438+09 and 2020 were lower than 2065.438+08.

6. As of June 65438+February 3, 20201,Neusoft Medical held 505 million yuan in cash and cash equivalents. In contrast, 20 19 was 776 million yuan in the same period, but it was11570,000 yuan by the end of February, decreasing year by year. In 20 18, 20 19 and 2020, Neusoft's medical R&D expenditure was 654.38+70 million yuan,10.8/10,000 yuan and 222 million yuan respectively, accounting for 8.9 1% of the total revenue. The sales and distribution expenses were 335 million yuan, 333 million yuan and 366.5438+0 million yuan respectively, which was about twice the R&D expenses in the same period.

7. By June 65438+February 3, 20201day, Neusoft Medical's global R&D team had employed 865 R&D professionals. According to the prospectus, its R&D team members have rich professional knowledge in the design and manufacture of medical imaging equipment, software engineering, artificial intelligence, cloud computing and other technologies.

8. According to the data of Wisdom Bud, Neusoft Medical applied for 283 patents. The earliest patent application was in 2002, and the patent growth rate in the past three years was 48.49%. Among them, non-appearance patents 124 1 piece accounted for 96.73%, including invention patents 1 150 pieces and utility models 9 1 piece.

9. In terms of technical field layout, Neusoft Medical's patents focus on detector, CT scanning, image reconstruction, medical equipment, scanning bed and other technical fields. According to the R&D team, Neusoft Medical has 839 inventors, among whom Lou Shanshan is the inventor with the largest number of inventions.

10. It is worth mentioning that Neusoft Medical once owned a number of patent transfer information. It is understood that the transfer of core patents may lead to a decline in the performance of the original business. However, Wisdom Bud data shows that Neusoft Medical has 205 patent transfer records, most of which are affiliated companies, and some of them are related to Philips (China) Investment Co., Ltd.